Haematopoietic stem cell transplant patients have a high initial failure rate to hepatitis B vaccination that can be overcome with subsequent vaccination series.

Autor: Shalabi RA; Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD, USA., Worst MA; Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD, USA., Hughes TE; Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD, USA., Walsh-Chocolaad T; Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD, USA., Cook L; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Gunn K; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Wells B; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Ciurea R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Aue G; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Tian X; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Childs RW; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2022 Mar; Vol. 196 (6), pp. 1404-1407. Date of Electronic Publication: 2021 Dec 08.
DOI: 10.1111/bjh.17991
Databáze: MEDLINE
Externí odkaz: